New York Assembly Bill A05392

New York 2025-2026 Regular Session

• Introduced: 2/13/25
• Refer: 2/13/25
• Report Pass: 5/27/25
• Refer: 5/27/25
• Report Pass: 5/29/25

Caption

Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.

Impact

The enactment of A05392 would require school districts, charter schools, and other educational entities to provide not just auto-injector devices but also these new nasal devices, ensuring that individuals who can administer the medication are adequately trained. This added responsibility may necessitate additional training protocols for school staff and emergency first responders to equip them with the skills needed to effectively administer the nasal sprays, which could streamline emergency medical responses across various settings.

Summary

Bill A05392 aims to expand the definition of epinephrine devices under New York public health law to include not only traditional auto-injectors but also epinephrine nasal sprays. This legislative change is intended to provide greater accessibility and options for treating anaphylactic reactions, which are serious allergic responses that can be life-threatening. The bill’s introduction addresses a growing concern about allergic reactions, particularly in schools and public places, where timely access to epinephrine is critical for saving lives during emergencies.

Contention

Some stakeholders have raised concerns about the potential burden that this expanded requirement may impose on educational and health entities. The worry is that without sufficient funding and resources, the effective implementation of this bill could be challenging, particularly in underfunded districts. Critics are also wary of the training requirements for administering the new devices, which could vary significantly based on local capabilities and expertise. Nonetheless, proponents assert that the benefits of having broader access to epinephrine treatments outweigh these concerns, emphasizing student safety and prompt medical response as paramount.

Implementation

If passed, the bill will grant health care practitioners the ability to prescribe nasal spray epinephrine devices as part of non-patient-specific prescriptions for schools and public places. This ensures that these devices are readily available where they are most needed. The bill will also clarify liability protections for educators and other personnel trained in the use of these emergency medical devices, reinforcing the legal safeguards for individuals acting to save lives during allergic emergencies.